Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study.
Trompet S, de Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Jukema JW; PROSPER Group. Trompet S, et al. Among authors: blauw gj. Exp Gerontol. 2008 Aug;43(8):801-5. doi: 10.1016/j.exger.2008.04.006. Epub 2008 Apr 22. Exp Gerontol. 2008. PMID: 18504081
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study.
Trompet S, Pons D, DE Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, Hyland M, Gaw A, Macfarlane PW, Packard CJ, Norrie J, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Jukema JW. Trompet S, et al. Among authors: blauw gj. Ann N Y Acad Sci. 2007 Apr;1100:189-98. doi: 10.1196/annals.1395.018. Ann N Y Acad Sci. 2007. PMID: 17460178 Clinical Trial.
HMG-CoA reductase inhibitors in the prevention of stroke.
van Mil AH, Westendorp RG, Bollen EL, Lagaay AM, Blauw GJ. van Mil AH, et al. Among authors: blauw gj. Drugs. 2000 Jan;59(1):1-6. doi: 10.2165/00003495-200059010-00001. Drugs. 2000. PMID: 10718096 Review.
Effect of pravastatin on cerebral infarcts and white matter lesions.
ten Dam VH, van den Heuvel DM, van Buchem MA, Westendorp RG, Bollen EL, Ford I, de Craen AJ, Blauw GJ; PROSPER Study Group. ten Dam VH, et al. Among authors: blauw gj. Neurology. 2005 May 24;64(10):1807-9. doi: 10.1212/01.WNL.0000161844.00797.73. Neurology. 2005. PMID: 15911821 Clinical Trial.
Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population.
van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, Olofsen H, Bollen EL, Jolles J, Murray HM, Blauw GJ, Westendorp RG, van Buchem MA. van den Heuvel DM, et al. Among authors: blauw gj. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):149-53. doi: 10.1136/jnnp.2005.070193. J Neurol Neurosurg Psychiatry. 2006. PMID: 16421114 Free PMC article. Clinical Trial.
Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study.
Versluis CE, van der Mast RC, van Buchem MA, Bollen EL, Blauw GJ, Eekhof JA, van der Wee NJ, de Craen AJ; PROSPER Study. Versluis CE, et al. Among authors: blauw gj. Int J Geriatr Psychiatry. 2006 Apr;21(4):375-81. doi: 10.1002/gps.1477. Int J Geriatr Psychiatry. 2006. PMID: 16534770
192 results